These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 153333)

  • 41. Inflammatory acne represents hypersensitivity to Propionibacterium acnes.
    Webster GF
    Dermatology; 1998; 196(1):80-1. PubMed ID: 9557234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines.
    Wang Y; Hata TR; Tong YL; Kao MS; Zouboulis CC; Gallo RL; Huang CM
    J Invest Dermatol; 2018 Nov; 138(11):2355-2364. PubMed ID: 29964032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans.
    Karvonen SL; Räsänen L; Cunliffe WJ; Holland KT; Karvonen J; Reunala T
    Dermatology; 1994; 189(4):344-9. PubMed ID: 7873817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Propionibacterium acnes and inflammation in acne; P. acnes has T-cell mitogenic activity.
    Jappe U; Ingham E; Henwood J; Holland KT
    Br J Dermatol; 2002 Feb; 146(2):202-9. PubMed ID: 11903228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytotoxicity in acne vulgaris].
    Vignale RA; Espasandín J; Lasalvia E; Borras A
    Med Cutan Ibero Lat Am; 1982; 10(1):31-6. PubMed ID: 6214674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
    Jain A; Sangal L; Basal E; Kaushal GP; Agarwal SK
    Dermatol Online J; 2002 Oct; 8(2):2. PubMed ID: 12546757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition.
    Lee WL; Shalita AR; Suntharalingam K; Fikrig SM
    Infect Immun; 1982 Jan; 35(1):71-8. PubMed ID: 7054130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
    Akamatsu H; Nishijima S; Takahashi M; Ushijima T; Asada Y
    J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients.
    Kistowska M; Meier B; Proust T; Feldmeyer L; Cozzio A; Kuendig T; Contassot E; French LE
    J Invest Dermatol; 2015 Jan; 135(1):110-118. PubMed ID: 25010142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin.
    Agak GW; Kao S; Ouyang K; Qin M; Moon D; Butt A; Kim J
    J Invest Dermatol; 2018 Feb; 138(2):316-324. PubMed ID: 28864077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levels of antibody to Staphylococcus epidermidis in patients with acne vulgaris.
    Puhvel SM; Warnick MA; Sternberg TH
    Arch Dermatol; 1965 Jul; 92(1):88-90. PubMed ID: 11850964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne.
    Białecka A; Mak M; Biedroń R; Bobek M; Kasprowicz A; Marcinkiewicz J
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):79-85. PubMed ID: 15761379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris.
    Mouser PE; Baker BS; Seaton ED; Chu AC
    J Invest Dermatol; 2003 Nov; 121(5):1226-8. PubMed ID: 14708633
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of lipase activities of Propionibacterium granulosum and Propionibacterium acnes.
    Higaki S; Nakamura M; Kitagawa T; Morohashi M; Yamagishi T
    Drugs Exp Clin Res; 2001; 27(5-6):161-4. PubMed ID: 11951573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Characteristics of the Propionibacterium strains isolated from acne patients].
    Białecka A; Kasprowicz A; Kaszycki P; Marcinkiewicz J
    Med Dosw Mikrobiol; 2004; 56(1):79-92. PubMed ID: 15524399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions.
    Holland KT; Cunliffe WJ; Eady EA
    J Med Microbiol; 1979 Feb; 12(1):71-82. PubMed ID: 34728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of the proinflammatory property of epidermal cyst contents: chemotactic C5a anaphylatoxin generation.
    Terui T; Rokugo M; Kato T; Tagami H
    Arch Dermatol Res; 1989; 281(1):31-4. PubMed ID: 2786384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of toll-like receptors by Propionibacterium acnes.
    Jugeau S; Tenaud I; Knol AC; Jarrousse V; Quereux G; Khammari A; Dreno B
    Br J Dermatol; 2005 Dec; 153(6):1105-13. PubMed ID: 16307644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammasome activation by Propionibacterium acnes: the story of IL-1 in acne continues to unfold.
    Thiboutot DM
    J Invest Dermatol; 2014 Mar; 134(3):595-597. PubMed ID: 24518111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.